OTC:TEVJF | Cash Flow Statement | TEVA PHARMACEUTICAL INDUSTRIES LTD

Complete source-backed cash-flow history.

Available history
2007-12-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$576M$411M-$491M-$1M
2026-03-31$369M-$40M$229M$13M
2025-12-31$480M$1.16B$165M$40M
2025-09-30$433M$369M$135M-$453M
2025-06-30$282M$227M$236M$6M
2025-03-31$214M-$105M$201M-$1.74B
2024-12-31-$217M$575M$202M-$674M
2024-09-30-$437M$693M$268M$0.00
2024-06-30-$846M$103M$178M-$966M
2024-03-31-$139M-$124M$144M-$151M
2023-12-31$463M$1.18B$301M-$576M
2023-09-30$69M$5M$184M-$576M
2023-06-30-$872M$324M$119M$302M-$55M
2023-03-31-$220M-$145M$139M$181M-$706M
2022-12-31-$1.31B$973M$142M$168M-$711M
2022-09-30$56M$543M$147M-$439M
2022-06-30-$232M$123M$127M$179M-$338M
2022-03-31-$955M-$49M$157M$161M$2M
2021-12-31-$159M$456M$153M$246M-$501M
2021-09-30$292M
2021-06-30$207M
2021-03-31$77M-$405M$150M$508M-$493M
2020-12-31$150M$331M$176M$141M-$125M
2020-09-30-$4.35B
2020-06-30$140M
2020-03-31$69M$305M$128M$252M-$700M
2019-12-31$109M$538M$119M$430M-$241M
2019-09-30-$314M
2019-06-30-$689M
2019-03-31-$105M$112M$125M$272M-$189M
2018-12-31-$2.89B$367M$213M$74M$0.00-$499M
2018-09-30-$208M
2018-06-30-$176M
2018-03-31$1.12B$1.5B$163M$1.04B$12M-$2.09B
2017-12-31-$11.54B$859M$267M$1.91B$87M-$2.51B
2017-09-30$595M
2017-06-30-$5.97B
2017-03-31$645M$136M$202M$1.52B$346M-$1.77B
2016-12-31-$973M$1.43B$333M-$797M$0.00$346M-$701M
2016-09-30$412M
2016-06-30$254M
2016-03-31$636M$1.38B$172M-$2.42B$0.00$307M$267M
2015-12-31$500M$1.62B$248M-$293M$0.00$290M$4.72B
2015-09-30$103M
2015-06-30$539M
2015-03-31$446M$1.35B$185M-$219M$439M$290M$93M
2014-12-31$687M$1.75B$300M-$347M$500M$272M-$593M
2014-09-30$876M$0.00
2014-06-30$748M$0.00
2014-03-31$744M$898M$225M-$388M$0.00$291M-$634M
2013-12-31$380M$816M$314M-$316M$0.00$276M-$619M
2013-09-30$711M$0.00
2013-06-30-$452M$297M
2013-04-01$200M
2013-03-31$630M$1.1B$264M-$266M$200M$281M-$2.26B
2012-12-31$320M$1.58B$327M-$409M$494M$214M$266M
2012-09-30-$79M$0.00
2012-06-30$863M$134M
2012-03-31$859M$756M$274M-$194M$134M$174M-$613M
2011-12-31$506M$1.43B$317M-$5.49B$150M$190M$4.09B
2011-09-30$916M$254M
2011-06-30$576M$95M
2011-03-31$761M$900M$234M-$676M$400M$203M-$770M
2010-12-31$771M$1.1B$234M-$216M$99M$172M-$573M
2010-09-30$1.05B
2010-06-30$797M
2010-03-31$713M$886M$165M-$328M$0.00$165M-$175M
2009-12-31$379M$957M$212M-$263M$141M-$213M
2009-09-30$649M
2009-06-30$521M
2009-03-31$451M$733M$160M-$142M$127M-$24M
2008-12-31-$694M$969M$181M-$3.86B$90M$1.96B
2008-09-30$631M
2008-06-30$533M
2008-03-31$139M$746M$142M$115M$95M$112M

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-12-31$1.41B$1.65B$737M-$2.15B
2024-12-31-$1.64B$1.25B$792M-$1.79B
2023-12-31-$559M$1.37B$968M-$1.91B
2022-12-31-$2.45B$1.59B$548M$656M-$1.49B
2021-12-31$417M$798M$562M$1.52B-$2.17B
2020-12-31-$3.99B$1.22B$578M$863M-$1.89B
2019-12-31-$999M$748M$525M$1.36B-$1.93B
2018-12-31-$2.15B$2.45B$651M$1.87B$12M-$3.35B
2017-12-31-$16.27B$2.23B$874M$3.45B$0.00$901M-$5.75B
2016-12-31$329M$3.89B$901M-$34.41B$0.00$1.3B$25.22B
2015-12-31$1.59B$5.54B$772M-$5.57B$439M$1.16B$4.81B
2014-12-31$3.06B$5.13B$929M-$1.45B$500M$1.16B-$2.38B
2013-12-31$1.27B$3.24B$1.03B-$1.15B$497M$1.09B-$3.88B
2012-12-31$1.96B$4.57B$1.1B-$1.13B$1.16B$855M-$1.68B
2011-12-31$2.76B$4.13B$1.05B-$7.6B$899M$800M$3.34B
2010-12-31$3.33B$4.14B$710M-$5.46B$99M$668M$573M
2009-12-31$2B$3.37B$719M-$916M$0.00$528M-$2.27B
2008-12-31$609M$3.23B$681M-$4.14B$0.00$388M$1.36B
2007-12-31$1.91B$1.81B$542M-$1.35B$152M$299M-$362M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.